Novozymes A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVZMF research report →
Price Chart
About the company
Novozymes A/S, a Danish enterprise established in 1925 and headquartered in Bagsvaerd, is a leading provider of biological solutions, specializing in the production and global distribution of industrial enzymes, microorganisms, and probiotics. Its extensive reach spans across Europe, the Middle East, Africa, North America, Asia Pacific, and Latin America. The company's diverse portfolio caters to a wide array of sectors, including the food and beverage industry with innovations for baking, beverages, dairy, starch processing, and protein applications.
- CEO
- Ester Baiget
- IPO
- 2010
- Employees
- 11,641
- HQ
- Lyngby, ND, DK
Get TickerSpark's AI analysis on NVZMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $32.50B
- P/E
- 43.22
- Fwd P/E
- 4.45
- PEG
- 1.81
- P/S
- 6.56
- P/B
- 2.53
- EV/EBITDA
- 17.99
- Div Yield
- 1.44%
- Gross Margin
- 54.89%
- Op Margin
- 21.24%
- Net Margin
- 14.70%
- ROE
- 5.79%
- ROIC
- 4.58%
Latest fiscal year · YoY change
- Revenue
- $4.16B+8.5%
- Gross Profit
- $2.24B+12.5%
- Op Income
- $882.60M
- Net Income
- $583.60M+91.0%
- EPS
- $1.25+86.6%
- OCF Growth
- +19.8%
- FCF Growth
- +13.7%
- 52W High
- $69.70
- 52W Low
- $52.10
- 50D MA
- $62.99
- 200D MA
- $60.85
- Beta
- 0.62
- RSI (14)
- 63
- Avg Volume
- 1.37K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the NVZMF Q2 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 73.9%
- Shares Outstanding
- 466.23M
- Float Shares
- 344.57M
Our NVZMF coverage
Recent articles, reports, and earnings notes.
No research on NVZMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NVZMF report →Novozymes A/S (OTCMKTS:NVZMF) Share Price Crosses Below Fifty Day Moving Average – Here’s What Happened
defenseworld.net · Feb 7
Novonesis A/S (NVZMF) Q2 2025 Earnings Call Transcript
seekingalpha.com · Aug 21
Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript
seekingalpha.com · May 11
Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript
seekingalpha.com · Feb 26
Novonesis A/S (NVZMF) Q3 2024 Earnings Call Transcript
seekingalpha.com · Nov 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.